Nuveen’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $232M | Sell |
2,893,244
-480,987
| -14% | -$39.7M | 0.06% | 236 |
|
|
2025
Q4 | $288M | Sell |
3,374,231
-1,167,195
| -26% | -$95.8M | 0.08% | 203 |
|
|
2025
Q3 | $353M | Sell |
4,541,426
-64,723
| -1% | -$5.06M | 0.09% | 179 |
|
|
2025
Q2 | $360M | Buy |
4,606,149
+41,008
| +0.9% | +$3.06M | 0.1% | 176 |
|
|
2025
Q1 | $331M | Buy |
4,565,141
+1,395,243
| +44% | +$99.9M | 0.1% | 185 |
|
|
2024
Q4 | $235M | Sell |
3,169,898
-216,591
| -6% | -$15.2M | 0.07% | 232 |
|
|
2024
Q3 | $223M | Buy |
3,386,489
+332,975
| +11% | +$24.2M | 0.06% | 240 |
|
|
2024
Q2 | $282M | Buy |
3,053,514
+474,260
| +18% | +$42M | 0.08% | 194 |
|
|
2024
Q1 | $246M | Sell |
2,579,254
-325,197
| -11% | -$27.3M | 0.07% | 226 |
|
|
2023
Q4 | $221M | Sell |
2,904,451
-530,398
| -15% | -$36.9M | 0.07% | 224 |
|
|
2023
Q3 | $238M | Sell |
3,434,849
-332,839
| -9% | -$26.7M | 0.08% | 197 |
|
|
2023
Q2 | $355M | Sell |
3,767,688
-1,227,000
| -25% | -$107M | 0.12% | 142 |
|
|
2023
Q1 | $413M | Sell |
4,994,688
-424,788
| -8% | -$33.4M | 0.15% | 128 |
|
|
2022
Q4 | $404M | Sell |
5,419,476
-141,672
| -3% | -$10.9M | 0.16% | 133 |
|
|
2022
Q3 | $460M | Sell |
5,561,148
-1,048,938
| -16% | -$101M | 0.19% | 112 |
|
|
2022
Q2 | $629M | Buy |
6,610,086
+458,309
| +7% | +$47.4M | 0.24% | 88 |
|
|
2022
Q1 | $686M | Buy |
6,151,777
+1,750,747
| +40% | +$196M | 0.22% | 96 |
|
|
2021
Q4 | $570M | Buy |
4,401,030
+1,533,795
| +53% | +$179M | 0.17% | 119 |
|
|
2021
Q3 | $325M | Sell |
2,867,235
-363,021
| -11% | -$41.4M | 0.1% | 188 |
|
|
2021
Q2 | $335M | Sell |
3,230,256
-121,771
| -4% | -$11.5M | 0.1% | 195 |
|
|
2021
Q1 | $280M | Sell |
3,352,027
-1,256,615
| -27% | -$106M | 0.09% | 208 |
|
|
2020
Q4 | $420M | Buy |
4,608,642
+351,774
| +8% | +$29.2M | 0.14% | 135 |
|
|
2020
Q3 | $340M | Sell |
4,256,868
-766,973
| -15% | -$59.8M | 0.13% | 149 |
|
|
2020
Q2 | $347M | Sell |
5,023,841
-1,286,875
| -20% | -$91.5M | 0.14% | 143 |
|
|
2020
Q1 | $397M | Sell |
6,310,716
-2,360,049
| -27% | -$170M | 0.19% | 111 |
|
|
2019
Q4 | $674M | Sell |
8,670,765
-2,574,039
| -23% | -$201M | 0.26% | 74 |
|
|
2019
Q3 | $824M | Sell |
11,244,804
-609,900
| -5% | -$42.8M | 0.33% | 59 |
|
|
2019
Q2 | $730M | Buy |
11,854,704
+11,713,215
| +8,279% | +$708M | 0.29% | 68 |
|
|
2019
Q1 | $9.02M | Sell |
141,489
-140,691
| -50% | -$8.03M | 0.05% | 431 |
|
|
2018
Q4 | $14.4M | Sell |
282,180
-52,017
| -16% | -$2.63M | 0.09% | 337 |
|
|
2018
Q3 | $19.4M | Buy |
334,197
+64,464
| +24% | +$3.15M | 0.1% | 315 |
|
|
2018
Q2 | $13.1M | Buy |
269,733
+253,344
| +1,546% | +$11.8M | 0.08% | 343 |
|
|
2018
Q1 | $762K | Sell |
16,389
-312
| -2% | -$13.5K | 0.01% | 812 |
|
|
2017
Q4 | $627K | Buy |
16,701
+6,570
| +65% | +$241K | ﹤0.01% | 860 |
|
|
2017
Q3 | $369K | Buy |
+10,131
| New | +$386K | ﹤0.01% | 963 |
|
|
2017
Q1 | – | Sell |
-597,096
| Closed | -$18.6M | – | 1402 |
|
|
2016
Q4 | $18.6M | Buy |
597,096
+61,167
| +11% | +$1.98M | 0.09% | 260 |
|
|
2016
Q3 | $21.5M | Buy |
535,929
+18,429
| +4% | +$694K | 0.13% | 192 |
|
|
2016
Q2 | $17.2M | Buy |
517,500
+473,934
| +1,088% | +$16.2M | 0.11% | 239 |
|
|
2016
Q1 | $1.28K | Sell |
43,566
-1,206
| -3% | -$33.3K | 0.01% | 930 |
|
|
2015
Q4 | $1.18K | Sell |
44,772
-4,170
| -9% | -$108K | 0.01% | 994 |
|
|
2015
Q3 | $1.16K | Sell |
48,942
-7,140
| -13% | -$172K | 0.01% | 1009 |
|
|
2015
Q2 | $1.33K | Sell |
56,082
-228,522
| -80% | -$5.16M | 0.01% | 1021 |
|
|
2015
Q1 | $6.76M | Buy |
284,604
+40,866
| +17% | +$917K | 0.04% | 457 |
|
|
2014
Q4 | $5.17M | Buy |
243,738
+30,600
| +14% | +$615K | 0.03% | 545 |
|
|
2014
Q3 | $3.63M | Buy |
213,138
+144,600
| +211% | +$2.28M | 0.02% | 626 |
|
|
2014
Q2 | $981K | Buy |
68,538
+20,622
| +43% | +$280K | 0.01% | 1185 |
|
|
2014
Q1 | $592K | Sell |
47,916
-1,560
| -3% | -$18K | ﹤0.01% | 1315 |
|
|
2013
Q4 | $542K | Buy |
+49,476
| New | +$558K | ﹤0.01% | 1297 |
|
|
2013
Q3 | – | Sell |
-53,100
| Closed | -$595K | – | 1497 |
|
|
2013
Q2 | $595K | Buy |
+53,100
| New | +$629K | ﹤0.01% | 1255 |
|
Other funds holding EW
VCM
VPM
Nuveen's EW Position: Q1 2026 in Review
Nuveen reduced its Edwards Lifesciences (EW) stake by 14% in Q1 2026, selling an estimated $39.7M and leaving 2,893,244 shares worth $232M. The position accounts for 0.06% of the portfolio, ranked #236.
Nuveen first reported a position in EW in Q2 2013 and has held it in 49 quarters since. The position peaked at $824M in Q3 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Nuveen held 2,893,244 shares of Edwards Lifesciences worth $232M as of Q1 2026.
- Nuveen sold 480,987 Edwards Lifesciences shares in Q1 2026, an estimated $39.7M.
- Edwards Lifesciences made up 0.06% of Nuveen's portfolio in Q1 2026, its #236 holding.
- Nuveen first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 49 quarters since.
- Nuveen's Edwards Lifesciences position peaked at $824M in Q3 2019.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.